Evaluation of the efficacy and safety of fluticasone furoate/vilanterol versus fluticasone propionate/salmeterol in COPD
Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients / Dransfield MT; Feldman G; Korenblat P; LaForce CF; Locantore N; Pistolesi M; Watkins ML; Crim C; Martinez FJ. - In: RESPIRATORY MEDICINE. - ISSN 0954-6111. - STAMPA. - 108:(2014), pp. 1171-1179.
Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients
PISTOLESI, MASSIMO;
2014
Abstract
Evaluation of the efficacy and safety of fluticasone furoate/vilanterol versus fluticasone propionate/salmeterol in COPD
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S0954611114001772-main.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Creative commons
Dimensione
559.19 kB
Formato
Adobe PDF
|
559.19 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
